20. Secondary acute angle-closure glaucoma due to Topiramate: A case report and literature review
Main Article Content
Abstract
We report a case of secondary acute angle-closure glaucoma occurring after the use of topiramate to treat migraine with typical clinical findings including bilateral, acute angle closure associated with elevated intraocular pressure, acute myopia and ciliochoroidal effusion. The patient was initially misdiagnosed with primary acute angle closure glaucoma, but later, her diagnosis was corrected and she was successfully treated with anti-glaucoma medications, cycloplegics, and corticosteroids. Through this case, we reviewed the literature on the pathogenesis, clinical features, laboratory findings and treatment considerations for this rare form of glaucoma.
Article Details
Keywords
Glaucoma, topiramate
References
2. Abtahi MA, Abtahi SH, Fazel F, et al. Topiramate and the vision: a systematic review. Clin Ophthalmol. 2012; 6:117-131. doi:10.2147/OPTH.S27695.
3. Park, Jong Su. Acute Myopia Induced by Topiramate Plus Phentermine for the Treatment of Obesity. Journal of Clinical Toxicology. 2012; 02(8). doi:10.4172/2161-0495.1000148.
4. Aminlari A, East M, Wei W, Quillen D. Topiramate induced acute angle closure glaucoma. Open Ophthalmol J. 2008; 2:46-47. Published 2008 Mar 28. doi:10.2174/1874364100802010046.
5. Koshi AK, Pathak AH, Patwardhan SD, Kulkarni AN. A Rare Case of Topiramate Induced Secondary Acute Angle Closure Glaucoma. J Clin Diagn Res. 2017; 11(6): ND01-ND03. doi:10.7860/JCDR/2017/28093.10052.
6. Abtahi SH, Abtahi MA, Roomizadeh P, Kasaei Z. Discrimination of topiramate induced angle closure glaucoma from primary angle closure glaucoma: the triple of age, pattern of clinical presentation and drug history. Arch Soc Esp Oftalmol. 2013; 88(2): 83-84. doi:10.1016/j.oftal.2012.05.009.
7. Mechrgui M, Kanani S. The Ophthalmic Side Effects of Topiramate: A Review. Cureus. 2022;14(8):e28513. Published 2022 Aug 28. doi:10.7759/cureus.28513.
8. Hesami O, Hosseini SS, Kazemi N, et al. Evaluation of Ocular Side Effects in the Patients on Topiramate Therapy for Control of Migrainous Headache. J Clin Diagn Res. 2016; 10(3): NC01-NC4. doi:10.7860/JCDR/2016/16263.7339.
9. Symes RJ, Etminan M, Mikelberg FS. Risk of angle-closure glaucoma with bupropion and topiramate. JAMA Ophthalmol. 2015; 133(10): 1187-1189. doi:10.1001/jamaophthalmol.2015.2180.
10. Thambi L, Kapcala LP, Chambers W, et al. Topiramate-associated secondary angle-closure glaucoma: a case series. Arch Ophthalmol. 2002; 120(8): 1108. doi:10.1001/archopht.120.8.1108.
11. Al Owaifeer AM, AlSultan ZM, Badawi AH. Topiramate-induced acute angle closure: A systematic review of case reports and case series. Indian J Ophthalmol. 2022; 70(5): 1491-1501. doi:10.4103/ijo.IJO_2134_21.
12. Czyz CN, Clark CM, Justice JD, Pokabla MJ, Weber PA. Delayed topiramate-induced bilateral angle-closure glaucoma. J Glaucoma. 2014; 23(8): 577-578. doi:10.1097/IJG.0b013e3182948491.
13. Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma. Am J Ophthalmol. 2004; 137(1): 193-195. doi:10.1016/s0002-9394(03)00774-8.
14. van Issum C, Mavrakanas N, Schutz JS, Shaarawy T. Topiramate-induced acute bilateral angle closure and myopia: pathophysiology and treatment controversies. Eur J Ophthalmol. 2011; 21(4): 404-409. doi:10.5301/EJO.2010.5979.
15. Alzendi NA, Badawi AH, Alhazzaa B, et al. Topiramate-induced angle closure glaucoma: Two unique case reports. Saudi J Ophthalmol. 2021; 34(3): 202-204. Published 2021 Feb 27. doi:10.4103/SJOPT.SJOPT_9_20.